Rechelist Pharma – CILOSTAZOL TABLET IP 50 MG (CILOZA TABLET)
CILOZA Tablet 50 mg by Rechelist Pharma contains Cilostazol IP 50 mg, a clinically proven antiplatelet and vasodilator medication. It is primarily prescribed to improve blood circulation in patients suffering from peripheral vascular disorders, particularly intermittent claudication associated with Peripheral Artery Disease (PAD).
Pharma Franchise Cilostazol Tablets IP 50 mg enhances blood flow by preventing platelet aggregation and widening narrowed blood vessels, helping patients walk longer distances without pain.
Composition
Each film-coated tablet contains:
- Cilostazol IP – 50 mg
- Excipients – Quantity sufficient
- Colour – As approved by regulatory authorities
Cilostazol belongs to the class of phosphodiesterase III (PDE-III) inhibitors, which work on both blood platelets and vascular smooth muscles.
Mechanism of Action
Cilostazol works through dual mechanisms:
1. Inhibition of Platelet Aggregation
It prevents platelets from sticking together, reducing the risk of clot formation.
2. Vasodilation
By relaxing smooth muscles in blood vessels, it widens arteries and improves blood flow, especially in the legs.
This dual action improves oxygen delivery to tissues and reduces pain caused by poor circulation.
Uses of CILOZA Tablet 50 mg
1. Intermittent Claudication
The primary indication. It reduces leg pain that occurs during walking due to poor blood supply.
2. Peripheral Artery Disease (PAD)
Improves walking distance and quality of life in PAD patients.
3. Prevention of Thrombotic Events (as prescribed)
In selected cases, it may be used to prevent clot-related complications under specialist supervision.
4. Post-Vascular Procedure Support
Sometimes prescribed after vascular interventions to maintain improved circulation.
Benefits of CILOZA Tablet
Improves Walking Distance
Patients with PAD can walk longer distances with reduced discomfort.
Enhances Blood Circulation
Promotes better arterial blood flow to extremities.
Reduces Leg Pain
Decreases cramping and pain during physical activity.
Dual Therapeutic Action
Acts as both antiplatelet and vasodilator in a single medication.
Non-Surgical Option
Provides medical management before considering invasive procedures.
Improves Quality of Life
Allows patients to maintain daily activities with less limitation.
Predictable Pharmacological Action
Well-studied and clinically validated molecule.
Dosage and Administration
- Usual dose: 50 mg twice daily or as directed by a physician.
- Should be taken at least 30 minutes before or 2 hours after meals.
- Swallow whole with water.
- Do not crush or chew.
Dose adjustments may be required based on medical condition and drug interactions.
Side Effects
Like all medications, PCD Pharma Franchise Cilostazol Tablets IP 50 mg Tablets may cause side effects. Most are mild and temporary.
Common Side Effects
- Headache
- Dizziness
- Diarrhea
- Palpitations
- Abdominal discomfort
Less Common Side Effects
- Swelling of ankles
- Nausea
- Increased heart rate
- Skin rash
Rare but Serious Side Effects
- Irregular heartbeat
- Severe bleeding
- Allergic reactions
- Chest pain
Immediate medical attention is required if severe symptoms occur.
Contraindications
CILOZA Tablet should not be used in:
- Patients with heart failure
- Severe liver impairment
- Active bleeding disorders
- Known hypersensitivity to Cilostazol
Precautions
- Use cautiously in patients with heart disease.
- Inform doctor if taking anticoagulants or other antiplatelet drugs.
- Regular monitoring may be required.
- Avoid use during pregnancy unless clearly needed.
- Not recommended during breastfeeding without medical advice.
Drug Interactions
Cilostazol may interact with:
- Aspirin and other antiplatelet drugs
- Warfarin
- Certain antifungal medications
- Some antibiotics
- Blood pressure medications
Always inform healthcare provider about ongoing medications.
Storage Instructions
- Store below 25°C.
- Protect from light and moisture.
- Keep out of reach of children.
Why Choose CILOZA Tablet by Rechelist Pharma?
- Manufactured under stringent quality standards.
- Accurate dosage strength for effective therapy.
- Reliable and consistent formulation.
- Trusted pharmaceutical manufacturing practices.
Clinical Importance
Peripheral Artery Disease is a progressive condition that can significantly limit mobility. Early pharmacological intervention with Cilostazol helps delay disease progression, reduce symptoms, and improve functional capacity. By improving microcirculation and preventing platelet aggregation, Third Party Manufacturing Cilostazol Tablets IP 50 mg Tablets plays a crucial role in vascular health management.
Conclusion
CILOSTAZOL TABLET IP 50 MG (CILOZA Tablet) from Rechelist Pharma is a clinically effective antiplatelet and vasodilator medicine indicated for the management of intermittent claudication and peripheral arterial disease. With its dual mechanism, proven safety profile, and ability to enhance walking performance, it offers significant therapeutic value for patients suffering from circulatory disorders. When used under medical supervision, it contributes to improved mobility, reduced vascular complications, and enhanced quality of life.
